CytomX Therapeutics Inc

NASDAQ:CTMX   3:59:51 PM EDT
1.65
+0.02 (+1.23%)
Earnings Announcements

Cytomx Therapeutics Reports Second Quarter 2022 Financial Results And Provides Business Update

Published: 08/04/2022 21:22 GMT
CytomX Therapeutics Inc (CTMX) - Cytomx Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update.
Qtrly Revenues $18.2 Million Versus $16.3 Million.
Qtrly Basic and Diluted Net Loss per Share $0.37.
Q2 Earnings per Share View $-0.36, Revenue View $17.9 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $18.15 Million
Adjusted EPS is expected to be -$0.30

Next Quarter Revenue Guidance is expected to be $19.21 Million
Next Quarter EPS Guidance is expected to be -$0.24

More details on our Analysts Page.